JAK/STAT Signaling
JAK/STAT Signaling(JAK/STAT 信号通路)
JAK/STAT Signaling 相关产品(544)
- GC44400Niclosamide (ethanolamine salt)CAS: 1420-04-8纯度: >98.00%
氯硝柳胺是一种经美国食品和药物管理局 (FDA) 批准用于治疗肠道蛔虫感染的驱虫药。
- GC45756Pimozide-d4CAS: 1803193-57-8纯度: >99.00%
An internal standard for the quantification of pimozide
- GC465032-(1,8-Naphthyridin-2-yl)phenol (2-NP)CAS: 65182-56-1纯度: >99.50% / >98.00%
An enhancer of STAT1 activity
- GC47303Erlotinib-d6 (hydrochloride)CAS: 1189953-78-3纯度: >99.00%
An internal standard for the quantification of erlotinib
- GC48839Nifuroxazide-d4CAS: 1188487-83-3纯度: >99.00%
An internal standard for the quantification of nifuroxazide
- GC50343HJC 0416 hydrochlorideCAS: 2415263-08-8
HJC 0416 hydrochloride 是一种有效的口服活性 STAT3 抑制剂，具有比 Stattic 更强的抗癌特性。 HJC 0416 hydrochloride 是一种用于乳腺癌研究的有前途的抗癌剂。
- GC50706JBJ-03-142-02CAS: 2068806-31-3纯度: >98.00%
Highly potent epidermal growth factor receptor (EGFR) and ErbB2 (human epidermal growth factor receptor; HER2) inhibitor
- GC60567Afatinib impurity 11CAS: 1402086-20-7纯度: >99.00%
Afatinib impurity 11 is an impurity of afatinib, an EGFR family inhibitor.
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44213 | ML115 | 912798-42-6 | >98.00% | |
A cell-permeable STAT3 activator | ||||
| GC44227 | MM-206 | 1809581-87-0 | >98.00% | |
A STAT3 inhibitor | ||||
| GC44263 | Myrtillin | 6906-38-3 | >99.50% / >98.00% | |
桃金娘苷（Delphinidin 3-o-glucoside）是一种花青素单体，主要分布于各种植物中，可用高效液相色谱法（HPLC）质谱法（Mass）和核磁共振法进行定性和定量分析(NMR)。 | ||||
| GC44400 | Niclosamide (ethanolamine salt) | 1420-04-8 | >98.00% | |
氯硝柳胺是一种经美国食品和药物管理局 (FDA) 批准用于治疗肠道蛔虫感染的驱虫药。 | ||||
| GC44491 | O-Desmethyl Gefitinib | 847949-49-9 | >98.00% | |
A major active metabolite of gefitinib | ||||
| GC44583 | PD 089828 | 179343-17-0 | >98.00% | |
An inhibitor of EGFR, PDGFβ, FGF, and c-Src | ||||
| GC44880 | SD 1029 | 118372-34-2 | >80.00% (mixture of isomers) | |
A JAK2 inhibitor | ||||
| GC45004 | TC 14012 (trifluoroacetate salt) | - | >95.00% | |
An antagonist of CXCR4 and agonist of CXCR7 | ||||
| GC45756 | Pimozide-d4 | 1803193-57-8 | >99.00% | |
An internal standard for the quantification of pimozide | ||||
| GC46503 | 2-(1,8-Naphthyridin-2-yl)phenol (2-NP) | 65182-56-1 | >99.50% / >98.00% | |
An enhancer of STAT1 activity | ||||
| GC47061 | CAY10763 | 2364458-49-9 | >98.00% | |
A dual inhibitor of IDO1 and STAT3 activation | ||||
| GC47303 | Erlotinib-d6 (hydrochloride) | 1189953-78-3 | >99.00% | |
An internal standard for the quantification of erlotinib | ||||
| GC48839 | Nifuroxazide-d4 | 1188487-83-3 | >99.00% | |
An internal standard for the quantification of nifuroxazide | ||||
| GC49139 | CAY10784 | 1245814-52-1 | >98.00% | |
A STAT3 inhibitor | ||||
| GC50013 | AG 1478 hydrochloride | 170449-18-0 | - | |
An inhibitor of EGF receptor kinase | ||||
| GC50026 | BIBX 1382 dihydrochloride | 1216920-18-1 | - | |
An EGFR inhibitor | ||||
| GC50066 | Atiprimod dihydrochloride | 130065-61-1 | - | |
JAK2 inhibitor | ||||
| GC50083 | PKI 166 hydrochloride | 2230253-82-2 | - | |
An inhibitor of EGFR | ||||
| GC50343 | HJC 0416 hydrochloride | 2415263-08-8 | - | |
HJC 0416 hydrochloride 是一种有效的口服活性 STAT3 抑制剂，具有比 Stattic 更强的抗癌特性。 HJC 0416 hydrochloride 是一种用于乳腺癌研究的有前途的抗癌剂。 | ||||
| GC50480 | PF 06651600 malonate | 2140301-97-7 | - | |
Potent and selective JAK3 inhibitor | ||||
| GC50706 | JBJ-03-142-02 | 2068806-31-3 | >98.00% | |
Highly potent epidermal growth factor receptor (EGFR) and ErbB2 (human epidermal growth factor receptor; HER2) inhibitor | ||||
| GC52293 | STAT3 Inhibitor 4m | - | >98.00% | |
A STAT3 inhibitor | ||||
| GC60154 | Erlotinib D6 | 1034651-23-4 | - | |
An internal standard for the quantification of erlotinib | ||||
| GC60567 | Afatinib impurity 11 | 1402086-20-7 | >99.00% | |
Afatinib impurity 11 is an impurity of afatinib, an EGFR family inhibitor. | ||||